Treating Or Preventing Abnormally High Heart Rate Patents (Class 607/14)
-
Patent number: 7386342Abstract: An implantable subcutaneous cardiac device includes at least two subcutaneous electrodes adapted for placement external to a heart beneath the skin of a patient. The device further includes an arrhythmia detector that detects a sustained tachyarrhythmia of the heart and a pulse generator that delivers anti-tachycardia pacing pulses to the subcutaneous electrodes in response to detection of a sustained tachyarrhythmia. The pacing pulses preferably have waveforms devoid of any exponential voltage decay and include rounded or substantially constant portions to minimize pain.Type: GrantFiled: September 8, 2004Date of Patent: June 10, 2008Assignee: Pacesetter, Inc.Inventors: Eric Falkenberg, Mark W. Kroll, Gene A. Bornzin
-
Publication number: 20080132965Abstract: The present invention is directed toward a detection architecture for use in implantable cardiac rhythm devices. The detection architecture of the present invention provides methods and devices for discriminating between arrhythmias. Moreover, by exploiting the enhanced specificity in the origin of the identified arrhythmia, the detection architecture can better discriminate between rhythms appropriate for device therapy and those that are not.Type: ApplicationFiled: February 11, 2008Publication date: June 5, 2008Inventors: Alan H. Ostroff, Jay A. Warren, Gust H. Bardy
-
Publication number: 20080132966Abstract: A method and apparatus for treatment of hypertension by electric stimulation of coronary artery baroreceptors wherein stimulation electrodes are implanted in the left coronary artery, periarterialy or in an adjacent coronary vein. Stimulation is non excitatory and does not cause heart contractions. Stimulation can be applied during the ventricular refractory period resulting in baroreceptor activation and subsequent reduction of blood pressure. An implantable device monitors ECG and applies to a field of stimulation of baroreceptors.Type: ApplicationFiled: December 5, 2007Publication date: June 5, 2008Applicant: G&L CONSULTING, LLCInventors: Howard Levin, Mark Gelfand
-
Publication number: 20080125824Abstract: Methods and systems for identifying tachyarrhythmia episode types and delivering therapy to mitigate the identified tachyarrhythmia episode types are described. Electrogram signals of cardiac activity are sensed and stored by an implantable cardiac device. Tachyarrhythmia episodes are detected and tachyarrhythmia episode types are identified based on characteristics of the electrogram signals. In preparation for performing ablation, a tachyarrhythmia episode is induced. The features of the induced tachyarrhythmia episode are compared to characteristics of the identified episode types. A similarity between the induced tachyarrhythmia episode and at least one of the episode types identified from the stored electrogram signals is indicated to facilitate performing the ablation.Type: ApplicationFiled: March 7, 2007Publication date: May 29, 2008Inventors: William H. Sauer, Shelley Marie Cazares, Dan Li
-
Publication number: 20080125825Abstract: Apparatus for treating a subject suffering from spontaneous atrial fibrillation includes an electrode device, adapted to be coupled to a vagus nerve of the subject, and a control unit, adapted to drive the electrode device to apply an electrical current to the vagus nerve, and to configure the current to maintain the spontaneous AF for at least about 24 hours, so as to modify blood flow within the atria and reduce risk of thromboembolic events.Type: ApplicationFiled: October 29, 2007Publication date: May 29, 2008Inventors: Omry Ben-Ezra, Ehud Cohen, Tamir Ben-David
-
Publication number: 20080119902Abstract: Methods and systems for classifying cardiac responses to pacing stimulation and managing retrograde conduction and pacemaker mediated tachyarrhythmia are described. An atrial pacing pulse and a ventricular pacing pulse are delivered during a paced cardiac cycle. A post ventricular atrial refractory period (PVARP) is timed following the ventricular pacing pulse. The system determines if the atrial pacing pulse captures the atrium. An atrial depolarization occurring after the paced cardiac cycle is sensed. Retrograde management is initiated if the atrial pacing pulse did not capture the atrium and the atrial depolarization occurred during the PVARP. Pacemaker mediated tachyarrhythmia (PMT) is initiated if the atrial pacing pulse did not capture the atrium and the atrial depolarization did not occur during the PVARP.Type: ApplicationFiled: November 17, 2006Publication date: May 22, 2008Inventors: Derek D. Bohn, Ankur Garg, Eric K. Enrooth
-
Patent number: 7376461Abstract: An algorithm executed in an implantable cardiac rhythm management device (CRMD) automatically adjusts the time that an atrial pace (AP) and/or a ventricular pace (VP) pulse is generated by a pulse generator when the expected time of occurrence of the AP pulse falls within a predetermined interval referred to as the “lowest tachy zone”. By delaying the generation of the AP pulse until outside of the lowest tachy zone, undersensing of ventricular tachycardia depolarizations due to cross-channel refractory and VP refractory is avoided.Type: GrantFiled: October 18, 2002Date of Patent: May 20, 2008Assignee: Cardiac Pacemakers, Inc.Inventors: David L. Perschbacher, Kenneth L. Baker
-
Patent number: 7353062Abstract: A cardiac rhythm management device is configured to discriminate between ventricular and supraventricular tachycardias (referred to as SVT/VT discrimination) by utilizing a morphology criterion in which the morphology of electrogram waveforms during ventricular beats are analyzed to determine if the beats are normally conducted. After the delivery of a cardioversion/defibrillation shock, however, the intraventricular conduction system is left in a modified state which alters the subsequently generated electrogram signal. Use of the morphology criterion for SVT/VT discrimination is discontinued after delivery of such a shock and resumed after a predetermined minimum number of normally conducted ventricular beats has been detected.Type: GrantFiled: December 24, 2003Date of Patent: April 1, 2008Assignee: Cardiac Pacemakers, Inc.Inventors: Jaeho Kim, Joseph M. Bocek, Eric G. Lovett
-
Patent number: 7346393Abstract: A cardiac rhythm management system for providing a plurality of therapy modalities. For example, the system may include a cardiac resynchronization therapy module for providing cardiac resynchronization therapy and a pacemaker module for providing bradycardia therapy, as well as a selector module coupled to the cardiac resynchronization therapy module and the bradycardia module. The selector module may select an operating mode from among a plurality of operating modes including the cardiac resynchronization therapy module and the pacemaker module. Various manual and automatic methods may be used to select the operating mode. In addition, a reversion management system may be included to assist the cardiac rhythm management system to recover in case of a disruption to the system.Type: GrantFiled: June 12, 2003Date of Patent: March 18, 2008Assignee: Cardiac Pacemakers, Inc.Inventors: Julio Spinelli, Qingsheng Zhu, Bruce H. Kenknight, Yinghong Yu, Jiang Ding
-
Patent number: 7346388Abstract: An implantable cardioverter/defibrillator (ICD) executes a rate accuracy enhancement algorithm to select measured atrial and ventricular intervals for classifying a detected tachycardia based on average atrial and ventricular rates calculated from the selected atrial and ventricular intervals. The detected tachycardia is classified as ventricular tachycardia (VT) if the average ventricular rate is substantially higher than the average atrial rate.Type: GrantFiled: February 10, 2005Date of Patent: March 18, 2008Assignee: Cardiac Pacemakers, Inc.Inventors: Bijan Elahi, Joseph M. Bocek, Jaeho Kim
-
Patent number: 7336997Abstract: Heart treatment equipment and a heart treatment method directed to prevention of a fatal arrhythmia by detecting a physical exercise or a mental stress by using a sensor and thereafter controlling the vagus nerve stimulation, wherein sensor means for detecting various living body information for generating a signal which designates degree of a sympathetic tone is provided and heart rate threshold for carrying out the vagus nerve stimulation is adjusted according to the living body information detected by the sensor means. Further, a nerve stimulation parameter for adjusting the strength of the vagus nerve stimulation is adjusted in response to the degree of the patient sympathetic tone.Type: GrantFiled: September 23, 2005Date of Patent: February 26, 2008Assignee: Terumo Kabushiki KaishaInventor: Yoshihito Fukui
-
Publication number: 20080027496Abstract: An implantable medical device operates according to a ventricular pacing protocol (VPP) that precludes ventricular pacing in any cardiac cycle where a sensed ventricular event has occurred in the preceding cycle. Improved ventricular sensing, detection and classification is provided.Type: ApplicationFiled: July 31, 2006Publication date: January 31, 2008Inventors: Todd J. Sheldon, Scott R. Stanslaski, Michael O. Sweeney, Robert A. Betzold, Douglas A. Hettrick
-
Patent number: 7317942Abstract: A method and medical device for discriminating an arrhythmia that includes an input circuit sensing cardiac signals and a microprocessor identifying an event associated with the sensed cardiac signals as a first arrhythmia event. A first circuit delivers a first therapy, substantially simultaneous with coupling of a charging circuit and an energy storage device to generate stored energy on the energy storage device, in response to the first arrhythmia event, and a control circuit controls delivery of the first therapy by the first circuit. The microprocessor evaluates a physiologic response to the delivered first therapy and determines the event is other than the first arrhythmia event in response to the evaluated physiologic response.Type: GrantFiled: May 5, 2004Date of Patent: January 8, 2008Assignee: Medtronic, Inc.Inventor: Mark L. Brown
-
Patent number: 7313438Abstract: A method and system for delivering anti-tachycardia pacing (ATP) is disclosed. By comparing the time intervals between senses from both ventricles, the origin of a ventricular tachyarrhythmia may be mapped to one or the other of the ventricles. The arrhythmic ventricle may then be paced with either single-ventricle or biventricular ATP pacing.Type: GrantFiled: June 1, 2004Date of Patent: December 25, 2007Assignee: Cardiac Pacemakers, Inc.Inventor: Yunlong Zhang
-
Patent number: 7313436Abstract: An implantable cardioverter defibrillator system and method are provided having configurable shock therapies selected based on an evaluation of the atrial rhythm status following a ventricular tachycardia or fibrillation detection. A dual chamber shock configuration is selected if the ventricular arrhythmia is co-existing with an atrial arrhythmia of recent onset. A ventricular only shock configuration is selected if the ventricular arrhythmia is co-existing with a sustained atrial arrhythmia.Type: GrantFiled: April 30, 2003Date of Patent: December 25, 2007Assignee: Medtronic, Inc.Inventor: Michael F. Hess
-
Patent number: 7308308Abstract: A method and apparatus for monitoring a patient's cardiac electrical activity is disclosed. The method includes determining a characteristic of the cardiac signals during a detected episode of atrial fibrillation. The method further includes comparing the characteristic to an atrial fibrillation therapy threshold and if the characteristic is less than or equal to the atrial fibrillation therapy threshold further comparing the characteristic to a self-termination threshold. If the characteristic is less than the self-termination threshold the method withholds anti-tachycardia therapy to allow the arrhythmia to self-terminate.Type: GrantFiled: April 25, 2005Date of Patent: December 11, 2007Assignee: Pacesetter, Inc.Inventors: Cecilia Qin Xi, Sergio Shkurovich
-
METHOD AND APPARATUS FOR CLOSED-LOOP CONTROL OF ANTI-TACHYARRHYTHMIA PACING USING HEMODYNAMIC SENSOR
Publication number: 20070282381Abstract: A cardiac rhythm management (CRM) system includes an implantable medical device that delivers anti-tachyarrhythmia therapies including anti-tachyarrhythmia pacing (ATP) and a hemodynamic sensor that senses a hemodynamic signal. The implantable medical device includes a hemodynamic sensor-controlled closed-loop ATP system that uses the hemodynamic signal for ATP capture verification. When ATP pulses are delivered according to a selected ATP protocol to terminate a tachyarrhythmia episode, the implantable medical device performs the ATP capture verification by detecting an effective cardiac contraction from the hemodynamic signal. The ATP protocol is adjusted using an outcome of the ATP capture verification.Type: ApplicationFiled: June 5, 2006Publication date: December 6, 2007Inventors: Dan Li, Cheng Zhang -
Publication number: 20070270913Abstract: A method and apparatus for controlling an atrial overdrive pacing therapy include detecting an atrial arrhythmia episode and determining if the atrial arrhythmia episode is an early recurring episode. Delivery of the atrial overdrive pacing therapy is enabled in response to the early recurring episode and commences upon detection of an atrial arrhythmia episode or a long pause.Type: ApplicationFiled: February 27, 2007Publication date: November 22, 2007Inventors: Lilian Kornet, Roger Kessels
-
Patent number: 7295873Abstract: Improved methods and devices perform tachycardia detection and anti-tachycardia pacing (ATP) to convert a tachycardia (e.g., VT or AT) to normal sinus rhythm. According to one embodiment, an anti-tachycardia pacing method includes sensing, during sinus rhythm, first and second cardiac signals at first and second sites, respectively, in a patient's heart. The first and second sites include left and right ventricles or left and right atria, for example. The method further includes sensing third and fourth cardiac signals at the first and second sites, respectively, during a tachycardia (e.g., ventricular tachycardia or atrial tachycardia). The cardiac signals are processed to provide respective values. One or more anti-tachycardia pacing pulses are delivered at the site closest to the reentrant circuit based on a comparison of a first ratio of the first and third values and a second ratio of the second and fourth values.Type: GrantFiled: July 15, 2004Date of Patent: November 13, 2007Assignee: Pacesetter, Inc.Inventors: Xiaoyi Min, Gene A. Bornzin, Mark W. Kroll
-
Patent number: 7289847Abstract: An apparatus and method of treating atrial fibrillation (AF) are provided. The apparatus includes means for detecting AF in a heart of a patient, means for classifying the AF as one of a plurality of AF types, means for selecting a therapy for delivery to the heart, from a plurality of therapies, based on AF type, and means for delivering the selected therapy to the heart. The plurality of therapies includes ATP therapy, a hybrid therapy including a combination of ATP therapy and drug therapy, and shock therapy. The method includes sensing an electrogram signal from the heart, analyzing the electrogram signal to detect AF in the heart, classifying the AF as one of a plurality of AF types, selecting a therapy for delivery to the heart, from a plurality of therapies, based on the AF type, and delivering the selected therapy to the heart.Type: GrantFiled: January 18, 2005Date of Patent: October 30, 2007Assignee: Pacesetter, Inc.Inventors: Jong Gill, Gene A. Bornzin
-
Patent number: 7283865Abstract: In a device and a method for determining a cardiac condition from a detected cardiac signal, an input signal is formed from the detected cardiac signal and supplied to an analysis unit. The analysis unit forms an analysis signal from the input signal, having a real part substantially corresponding to the input signal and an imaginary part that is a predetermined transformation of the input signal. A calculation unit operates on the analysis signal to calculated at least two heart-related parameters therefrom. The heart-related parameters are supplied to a processing unit that combines the heart-related parameters in a predetermined manner for identifying a cardiac condition.Type: GrantFiled: February 27, 2003Date of Patent: October 16, 2007Assignee: St. Jude Medical ABInventor: Kjell Norén
-
Patent number: 7280869Abstract: In general, the invention is directed to an apparatus and method for determining whether an identified atrial tachyarrhythmia episode has terminated. The invention enables determination of whether the tachyarrhythmia episode has terminated based on cardiac beat pattern. In some embodiments of the invention, the determination as to whether the episode has terminated is made irrespective of the rate of atrial depolarizations.Type: GrantFiled: December 3, 2004Date of Patent: October 9, 2007Assignee: Medtronic, Inc.Inventors: Eduardo N. Warman, Jacob D. Feala
-
Patent number: 7277755Abstract: An implantable subcutaneous cardiac device includes at least two subcutaneous electrodes adapted for placement external to a heart beneath the skin of a patient. The device further includes an arrhythmia detector that detects a sustained tachyarrhythmia of the heart and a pulse generator that delivers anti-tachycardia pacing pulses to the subcutaneous electrodes in response to detection of a sustained tachyarrhythmia. The pacing pulses preferably have waveforms devoid of any exponential voltage decay and include rounded or substantially constant portions to minimize pain.Type: GrantFiled: September 8, 2004Date of Patent: October 2, 2007Assignee: Pacesetter, Inc.Inventors: Eric Falkenberg, Mark W. Kroll, Gene A. Bornzin
-
Patent number: 7277750Abstract: An implantable cardioverter/defibrillator (ICD) includes an Anti-Tachycardia Pacing Before Charge (ATP-BC) mode according to which one or more high-voltage capacitors for storing defibrillation energy are charged in preparation of delivering a defibrillation shock only if a ventricular tachycardia (VT) sustains after an ATP delivery. Fast ATP delivery and effect verification methods are applied to avoid significant delay in delivering the defibrillation shock when found necessary to terminate the VT. A switch is provided such that a user decides whether to activate the ATP-BC mode or to deliver the defibrillation shock without delivering the ATP.Type: GrantFiled: April 2, 2004Date of Patent: October 2, 2007Assignee: Cardiac Pacemakers, Inc.Inventors: David L. Perschbacher, Karin K. Roof, Rebecca Bloomfield
-
Patent number: 7277756Abstract: A system comprising an implantable medical device (IMD). The IMD comprises a ventricular heart signal sensing circuit to provide a ventricular heart signal, at least one sensor operable to provide an electrical signal representative of patient activity, a sensor interface circuit coupled to the at least one sensor to provide an activity signal, and a controller circuit coupled to the heart signal sensing circuit and the sensor interface circuit. The controller circuit is operable to determine whether ventricular ectopy occurs during recovery from exercise using the heart signal, and to set at least one warning indicator if ventricular ectopy occurs during the recovery from exercise.Type: GrantFiled: August 16, 2004Date of Patent: October 2, 2007Assignee: Cardiac Pacemakers, Inc.Inventors: Mitchell Smith, Mark Schwartz
-
Patent number: 7272438Abstract: In a heart stimulation device a mode of operation is switched in response to detection of atrial tachyarrhythmia such as atrial fibrillation. The stimulation device may initially operate in a normal mode of pacing then, upon detection of atrial tachyarrhythmia, the stimulation device may change how it senses signals and it may switch to another mode of pacing at one or more sites in the ventricle.Type: GrantFiled: October 12, 2004Date of Patent: September 18, 2007Assignee: Pacesetter, Inc.Inventors: Mark W. Kroll, Paul A. Levine
-
Patent number: 7260433Abstract: An implantable subcutaneous cardiac device includes at least two subcutaneous electrodes adapted for placement external to a heart beneath the skin of a patient. The device further includes an arrhythmia detector that detects a sustained tachyarrhythmia of the heart and a pulse generator that delivers anti-tachycardia pacing pulses to the subcutaneous electrodes in response to detection of a sustained tachyarrhythmia. The pacing pulses preferably have waveforms devoid of any exponential voltage decay and include rounded or substantially constant portions to minimize pain.Type: GrantFiled: September 8, 2004Date of Patent: August 21, 2007Assignee: Pacesetter, Inc.Inventors: Eric Falkenberg, Mark W. Kroll, Gene A. Bornzin
-
Publication number: 20070191898Abstract: A method and device for delivering anti-tachycardia pacing (ATP) therapy that includes an electrode to sense cardiac signals and to deliver the therapy, sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals, and a processor to control delivery of the therapy. The processor determines whether a return cycle length generated subsequent to the delivery of the first plurality of pacing pulses is greater than or equal to a sum of a cycle length associated with the tachycardia event and a total prematurity associated with the first plurality of pacing pulses, and adjusts delivery of a second plurality of pacing pulses in response to the return cycle length being greater than or equal to a sum of a cycle length associated with the tachycardia event and a total prematurity associated with the first plurality of pacing pulses.Type: ApplicationFiled: February 15, 2007Publication date: August 16, 2007Inventors: Paul A. Belk, Troy E. Jackson
-
Publication number: 20070191899Abstract: A method and device for delivering anti-tachycardia pacing (ATP) therapy that includes an electrode to sense cardiac signals and to deliver the therapy, sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals, and a processor to control delivery of the therapy.Type: ApplicationFiled: February 15, 2007Publication date: August 16, 2007Inventors: Paul A. Belk, Troy E. Jackson
-
Publication number: 20070191896Abstract: A method and device for delivering anti-tachycardia pacing (ATP) therapy that includes an electrode to sense cardiac signals and to deliver the therapy, sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals, and a processor to control delivery of the therapy.Type: ApplicationFiled: February 15, 2007Publication date: August 16, 2007Inventors: Paul A. Belk, Troy E. Jackson
-
Publication number: 20070191900Abstract: A method and device for delivering anti-tachycardia pacing (ATP) therapy that includes an electrode to sense cardiac signals and to deliver the therapy, sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals, and a processor to control delivery of the therapy. The processor determines a cause of the delivered first plurality of pacing pulses failing to terminate the tachycardia event as a result of one of a failure to capture the tachycardia event, a failure to complete peelback, and a failure to entrain a reentrant circuit associated with the tachycardia event, and adjusts delivery of a second plurality of pacing pulses subsequent to the delivery of the first plurality of pacing pulses in response to the determined cause.Type: ApplicationFiled: February 15, 2007Publication date: August 16, 2007Inventors: Paul A. Belk, Troy E. Jackson
-
Publication number: 20070191897Abstract: A method and device for delivering anti-tachycardia pacing (ATP) therapy that includes an electrode to sense cardiac signals and to deliver the therapy, sensing circuitry, electrically coupled to the electrode, to detect the tachycardia event in response to the sensed cardiac signals, and a processor to control delivery of the therapy. The processor determines whether a return cycle length generated subsequent to the delivery of a first plurality of pacing pulses is less than or equal to a cycle length associated with the tachycardia event, and adjusts delivery of a second plurality of pacing pulses in response to the return cycle length being less than or equal to the cycle length associated with the tachycardia event.Type: ApplicationFiled: February 15, 2007Publication date: August 16, 2007Inventors: Paul A. Belk, Troy E. Jackson
-
Patent number: 7257443Abstract: A cardiac rhythm management device is configured to detect oscillations in cardiac rhythm by comparing electrogram signals during successive heart beats. Upon detection of electrical alternans, the device may adjust its operating behavior to compensate for the deleterious effects of the condition.Type: GrantFiled: July 19, 2005Date of Patent: August 14, 2007Assignee: Cardiac Pacemakers, Inc.Inventors: Joseph M. Pastore, Steven D. Girouard, Bruce H. KenKnight, Qingsheng Zhu, Jiang Ding
-
Patent number: 7251526Abstract: An active implantable medical device of the defibrillator, cardiovertor and/or antitachycardia pacemaker type having a high maximum frequency for antibradycardia stimulation. This device provides antibradycardia stimulation at a stimulation frequency that has a programmed maximum stimulation frequency. For a detected rate exceeding a given frequency threshold, the device analyzes the cardiac activity to discriminate a ventricular tachycardia or fibrillation to command in consequence an appropriate antitachycardia therapy. The maximum stimulation frequency for antibradycardia is higher than the given frequency threshold for the antitachycardia analysis, and the cardiac rhythm is analyzed to detect a particular succession of events that are likely to reveal the presence or the appearance of a ventricular tachycardia during such high antibradycardia stimulation.Type: GrantFiled: September 16, 2003Date of Patent: July 31, 2007Assignee: ELA Medical S.A.S.Inventors: Christine Henry, Laurence Graindorge
-
Patent number: 7248922Abstract: A device and method for cardiac rhythm management in which a heart chamber is paced in accordance with a pacing mode that employs sense signals from the opposite chamber. A sensing refractory period is provided in order to prevent the pacing interval from being lengthened due to delays in conduction of excitation from the paced chamber to the sensed chamber.Type: GrantFiled: March 5, 2004Date of Patent: July 24, 2007Assignee: Cardiac Pacemakers, Inc.Inventor: Kenneth L. Baker
-
Patent number: 7245968Abstract: An implantable cardiac device that delivers electrical therapy to a patient's heart determines if a T wave alternan pattern of the patient's heart exists. The device includes a sensing circuit that generates an electrical signal including T waves representing paced electrical activity of the heart and a morphology detector that measures a metric of each T wave in the electrical signal. A T wave alternan pattern detector determines, responsive to the measured T wave metrics, if a paced activity T wave alternan pattern is present. The T wave alternan pattern detector may also detect for intrinsic T wave alternan patterns. A therapy control initiates suitable different responses for a paced T wave alternan pattern detection and an intrinsic T wave alternan pattern detection.Type: GrantFiled: June 14, 2004Date of Patent: July 17, 2007Assignee: Pacesetter, Inc.Inventors: Taraneh Farazi, Euljoon Park
-
Patent number: 7245967Abstract: Terminating supraventricular arrhythmias through parasympathetic nerve stimulation. The method comprises detecting a supraventricular arrhythmia, stimulating a parasympathetic nerve and determining whether the supraventricular arrhythmia terminated or worsened. Various exemplary methods include delivering one or more stimulation pulses during postinspiration and/or in response to one or more cardiac events.Type: GrantFiled: June 11, 2003Date of Patent: July 17, 2007Assignee: Pacesetter, Inc.Inventor: Anne M. Shelchuk
-
Patent number: 7245965Abstract: An implantable cardiac stimulation device, mode switchable between atrial tracking and atrial non-tracking pacing modes includes a threshold control for controlling atrial sensing threshold. The threshold control reduces the sensing threshold from a first threshold used during the atrial tracking pacing mode to a second threshold between the first threshold and the noise for use during the atrial non-tracking pacing mode. The necessity for readjusting the atrial sensing threshold is based upon the ratio of the sensing threshold and atrial amplitudes or upon a diagnostic distribution of atrial amplitudes.Type: GrantFiled: June 18, 2003Date of Patent: July 17, 2007Assignee: Pacesetter, Inc.Inventors: Xing Pei, Xiaoyi Min
-
Patent number: 7242978Abstract: An implantable medical device and associated method for automatically generating morphology templates during fast cardiac rhythms, confirming a provisional template as a confirmed template, and using the confirmed template to classify subsequent detected arrhythmias. A provisional SVT template may be created during a fast ventricular rate and activated as a confirmed SVT template upon verification that the fast rate was due to an SVT. The confirmed SVT template may be used to discriminate SVT from VT/VF.Type: GrantFiled: December 2, 2004Date of Patent: July 10, 2007Assignee: Medtronic, Inc.Inventors: Jian Cao, Jeffrey M. Gillberg, Chris J. Gennaro
-
Patent number: 7233821Abstract: A method of evaluating ventricular performance of a heart employing sensors to measure a ventricular dimension signal and deriving indices of ventricular performance therefrom. Premature Shortening (PS) and Isovolumic Lengthening (IL) comprise two indices of ventricular performance determined from analysis of the left ventricular dimension signal during the transition from ventricular filling to ventricular ejection. Measured values of PS and IL are compared to other measured values or reference values to determine if ventricular performance has improved (or worsened). In some embodiments, the dimension sensors may comprise piezoelectric sonomicrometer crystals that operate as ultrasound transmitters and receivers. The sensors may be mounted in relation to a ventricle of the heart either temporarily or permanently, and may be configured either separately from or integrally with cardiac pacing leads.Type: GrantFiled: March 31, 2005Date of Patent: June 19, 2007Assignee: Medtronic, Inc.Inventors: Douglas A. Hettrick, David E. Euler
-
Patent number: 7233824Abstract: An extra-systolic stimulation (ESS) therapy addresses cardiac dysfunction including heart failure. ESS therapy employs atrial and/or ventricular extra-systoles via pacing-level stimulation to a heart. These extra-systoles must be timed correctly to achieve beneficial effects on myocardial mechanics (efficacy) while maintaining an extremely low level of risk of arrhythmia induction and excellent ICD-like arrhythmia sensing and detection (security). The present invention relates to therapy delivery guidance and options for improved ESS therapy delivery. These methods may be employed individually or in combinations in an external or implantable ESS therapy delivery device.Type: GrantFiled: November 7, 2003Date of Patent: June 19, 2007Assignee: Medtronic, Inc.Inventors: Karen J. Kleckner, Kathleen A. Prieve, Jeffrey M. Gillberg, Ren Zhou, Kenneth M. Anderson, D. Curtis Deno, Glenn C. Zillmer, Ruth N. Klepfer, Vincent E. Splett
-
Patent number: 7231248Abstract: A method and system for setting the operating parameters of a cardiac rhythm management device in which a plurality of parameter optimization algorithms are available. A measured feature of an electrophysiological signal such as QRS width has been shown to be useful in selecting among certain parameter optimization algorithms. In one embodiment, one or more resynchronization pacing parameters are set based on one or both of the feature extracted from an electrogram signal and the value of a resynchronization pacing parameter which tends to minimize the intrinsic atrial rate.Type: GrantFiled: July 21, 2003Date of Patent: June 12, 2007Assignee: Cardiac Pacemakers, Inc.Inventors: Andrew P. Kramer, Veerichetty Kadhiresan, Jiang Ding, Lawrence Baumann, Scott Vanderlinde
-
Patent number: 7228176Abstract: This document discusses, among other things, systems, devices, and methods for detecting or classifying tachyarrhythmias or making a therapy decision. In one example, a rate-dependent threshold is used for comparing atrial and ventricular rates for classifying a tachyarrhythmia as a ventricular tachyarrhythmia (VT) or a supraventricular tachyarrhythmia (SVT). In another example, the classification uses an atrial rate cutoff value, a ventricular rate cutoff value, or both. In another example, a tachyarrhythmia detection is tested over a time window with a duration that is automatically adjusted as a substantially continuously monotonically decreasing function of duration vs. rate. These techniques improve the specificity of arrhythmia detection or classification, allow anti-tachyarrhythmia therapy to be better tailored to the particular tachyarrhythmia, or provide more automatic operation making it easier for a physician to use an implantable device.Type: GrantFiled: July 22, 2004Date of Patent: June 5, 2007Assignee: Cardiac Pacemakers, Inc.Inventors: Valerie Smith, Richard Milon Dujmovic, Jr., Julie Thompson
-
Patent number: 7228173Abstract: Cardiac treatment methods and devices providing templates representative of past tachyarrythmia events, each template associated with a therapy. A cardiac waveform is detected, and if it corresponds to a particular template associated with a previous therapy that was satisfactory in terminating a past event, the previous therapy is delivered again. If unsatisfactory, the previous therapy is eliminated as an option. If, for example, the previous therapy was an antitachycardia pacing therapy unsatisfactory in terminating the past tachyarrythmia event, delivery of the antitachycardia pacing therapy is eliminated as an option. Instead of ATP therapy, one or more of a cardioversion, defibrillation, or alternate anti-tachycardia pacing therapy may be associated with the particular template.Type: GrantFiled: November 23, 2004Date of Patent: June 5, 2007Assignee: Cardiac Pacemakers, Inc.Inventor: Shelley Marie Cazares
-
Patent number: 7225020Abstract: Techniques for enabling both preventive overdrive pacing and antitachycardia pacing (ATP) within an implantable device are provided. The device gains the benefits of overdrive pacing for preventing the onset of a tachycardia and, if one nevertheless occurs, ATP is employed to terminate the tachycardia. In particular, a technique is provided for promptly detecting the onset of atrial tachycardia during preventive overdrive pacing based on loss of capture of atrial pacing pulses. A technique is also provided for using detection of loss of capture of atrial or ventricular pacing pulses to trigger automatic switching from overdrive pacing to ATP. A setup technique determines whether to enable the automatic switching from overdrive pacing to ATP within a particular patient. Also, techniques are provided for verifying loss of capture of atrial or ventricular backup pacing pulses and for detecting low amplitude ventricular fibrillation based on loss of capture of ventricular backup pacing pulses.Type: GrantFiled: September 8, 2003Date of Patent: May 29, 2007Assignee: Pacesetter, Inc.Inventors: Mark W. Kroll, Eric Falkenberg, Paul A. Levine
-
Patent number: 7212855Abstract: Techniques for enabling both preventive overdrive pacing and antitachycardia pacing (ATP) within an implantable device are provided. The device gains the benefits of overdrive pacing for preventing the onset of a tachycardia and, if one nevertheless occurs, ATP is employed to terminate the tachycardia. In particular, a technique is provided for promptly detecting the onset of atrial tachycardia during preventive overdrive pacing based on loss of capture of atrial pacing pulses. A technique is also provided for using detection of loss of capture of atrial or ventricular pacing pulses to trigger automatic switching from overdrive pacing to ATP. A setup technique determines whether to enable the automatic switching from overdrive pacing to ATP within a particular patient. Also, techniques are provided for verifying loss of capture of atrial or ventricular backup pacing pulses and for detecting low amplitude ventricular fibrillation based on loss of capture of ventricular backup pacing pulses.Type: GrantFiled: September 8, 2003Date of Patent: May 1, 2007Assignee: Pacesetter, Inc.Inventors: Mark W. Kroll, Eric Falkenberg, Paul A. Levine
-
Patent number: 7212860Abstract: A method for operating a cardiac pacemaker in which the mode of operation of the pacemaker is altered in response to detecting an episode of atrial tachycardia. In accordance with the invention, the pacemaker's pacing mode is altered in a manner that attempts to maintain hemodynamic stability during the atrial tachycardia. Such a mode switch is particularly applicable to pacemaker patients suffering from some degree of congestive heart failure.Type: GrantFiled: November 13, 2003Date of Patent: May 1, 2007Assignee: Cardiac Pacemakers, Inc.Inventors: Jeffrey E. Stahmann, Andrew P. Kramer
-
Patent number: 7212859Abstract: An implantable cardiac stimulation system delivers arrhythmia termination pulses to the ventricles and the atria of a heart. The system includes an implantable cardiac stimulation device, including a conductive enclosure, ventricular arrhythmia termination pulse generator, and an atrial arrhythmia termination pulse generator. A first electrode configuration, including the conductive enclosure, is arranged to be coupled to the ventricular pulse generator to terminate ventricular arrhythmias and a second electrode configuration, electrically independent from the conductive enclosure and confined within the heart, is arranged to be coupled to the atrial pulse generator to terminate atrial arrhythmias.Type: GrantFiled: July 26, 2002Date of Patent: May 1, 2007Assignee: Pacesetter, Inc.Inventor: Mark W. Kroll
-
Patent number: 7206633Abstract: A method discriminates between ventricular arrhythmia and supraventricular tachycardia by detecting an earliest arriving electrical signal following anti-tachycardia pacing. An implantable cardiac defibrillator provides simultaneous atrioventricular anti-tachycardia pacing bursts and detects an earliest arriving electrical signal. This discrimination capability reduces the incidence of inappropriate shocks from dual-chamber implantable cardiac defibrillators to near zero and provides a method to differentially diagnose supraventricular tachycardia from ventricular tachycardia.Type: GrantFiled: November 19, 2003Date of Patent: April 17, 2007Assignee: University of PittsburghInventor: Samir F. Saba
-
Patent number: 7203538Abstract: A device and method are presented for prolonging the atrial effective refractory period with pacing therapy. Such refractory period prolongation renders the atrial tissue less susceptible to the onset of atrial fibrillation. A particularly useful application is during the period after application of electrical therapy to the atria.to terminate an episode of atrial fibrillation.Type: GrantFiled: November 22, 2002Date of Patent: April 10, 2007Assignee: Cardiac Pacemakers, Inc.Inventors: Mark Schwartz, Jasbir Sra